McCarthy Sean A.

CIK 00016540581 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001654058

Recent Transactions

50 trades

Sale
CytomX Therapeutics, Inc.$CTMX
Class A Common Stock
2025-11-06$4.54/sh−101,793→ 987,891 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-09-26+570,000→ 570,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2025-09-26+285,000→ 285,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-06-16$2.69/sh−55,511→ 1,089,684 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units
2025-06-13−150,000→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-06-13+150,000→ 1,145,195 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-03-18$0.60/sh−37,656→ 995,195 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+180,000→ 837,851 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+195,000→ 1,032,851 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+390,000→ 390,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+800,000→ 800,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20$1.23/sh−13,898→ 657,851 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-08-20−37,500→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-08-20+37,500→ 671,749 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-03-26$1.57/sh+109,768→ 634,249 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-03-26−109,768→ 0 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-03-19$2.09/sh−20,223→ 524,481 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-01-18+90,000→ 544,704 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-01-18+420,000→ 420,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-01-18+260,000→ 260,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-12-20$1.38/sh−13,551→ 454,704 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2023-12-17−37,500→ 37,500 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-12-17+37,500→ 468,255 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-22$1.30/sh−14,601→ 430,755 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-09-20+40,000→ 445,356 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2023-05-19−16,535→ 119,536 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-05-19$1.57/sh+16,535→ 405,356 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-03-16$1.88/sh−7,121→ 388,821 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2023-02-02+300,000→ 300,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2023-02-02+315,000→ 315,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2023-02-02+105,000→ 395,942 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2022-08-10+75,000→ 75,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-08-10+450,000→ 450,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-07-20$1.42/sh−14,911→ 290,942 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-07-19+40,000→ 305,853 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-05-09−24,189→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-05-09$0.94/sh+24,189→ 265,853 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-05-09−66,742→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-05-09$0.94/sh+66,742→ 241,664 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-02-02+450,000→ 450,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-02-02+75,000→ 174,922 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2021-10-24+80,000→ 80,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2021-10-24+100,000→ 100,000 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2021-08-11−92,113→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2021-08-11$1.13/sh+92,113→ 99,922 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2021-06-16$7.04/sh−100,000→ 93,118 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2021-06-14−10→ 66,742 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2021-06-14$1.13/sh+30→ 7,839 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2021-06-14$0.94/sh+10→ 7,849 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2021-06-14−30→ 92,113 total

Companies

CytomX Therapeutics, Inc.
Director, CEO
$CTMX

Recent Filings

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov